GlassScriptPhysician profile
Bradley Pansing
NPI 1427553973
$3,056.58
in general payments reported to CMS, 2019-2025
11 companies · $667 in 2025
The $667 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $47.53 · 2023: $942 · 2024: $1,400 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,257 · Education: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,256.51 |
| Education | $752.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,213.11 | 2024-2025 | Endurant Iis |
| W. L. Gore & Associates, INC. | $1,122.55 | 2023-2025 | Gore-Tex Vascular Graft, Gore Tag Thoracic Branch Endoprosthesis, Gore Viabahn Endoprosthesis |
| Penumbra, INC. | $163.02 | 2025 | Indigo System |
| Bolton Medical INC | $147.92 | 2023 | Treo Abdominal Stent-Graft System |
| Silk Road Medical, INC. | $129.34 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Solventum Corporation | $117.42 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Integra Lifesciences Corporation | $59.50 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Boston Scientific Corporation | $50.20 | 2025 | General - Vascular Intervention |
| Abbott Laboratories | $22.46 | 2023 | Perclose Prostyle |
| Allergan, INC. | $17.11 | 2022 | |
| Philips North America LLC | $13.95 | 2025 | IV Other |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Pansing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.